ArticleDiscover oncology2025
Knowledge mapping of micro/nanomotors in cancer treatment: a bibliometric analysis (2006-2025).
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Light force-powered cellular medical micromachines.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalignant tumors present challenges such as high heterogeneity and the limitations of traditional therapies, driving innovations in nanomedicine, particularly in the development of micro/nanomotors. These autonomous devices offer superior tumor penetration capabilities but and lack systematic bibliometric insights.
methodData from WoSCC (2006-2025) were analyzed using bibliometric tools (CiteSpace, VOSviewer, and "bibliometrics") to map research landscapes.
resultsA total of 10,609 articles from 38 countries were identified, with annual output growing at a compound annual growth rate (CAGR) of 22% and peaking at 126 articles in 2024. China led globally with 380 publications (62.4%). The Chinese Academy of Sciences (123 articles) emerged as the leading institution in this domain, while ACS NANO (36 articles) was identified as the most prolific and co-cited journal. Wang J contributed the highest number of articles, and publications by Wang J also exhibited the highest co-citation frequency. The keyword "penetration" exhibited the strongest citation burst (2021-2025), reflecting breakthroughs in overcoming tumor physical barriers.
conclusionThis study highlights China's dominance, rapid technological evolution toward intelligent actuation and immunotherapy integration, and "penetration" as a pivotal frontier. Findings provide strategic guidance for future research and clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.